In Japan, the mortality rate for malignant neoplasms of the colon, rectum, and anus among men is forecasted to rise from 47.7 deaths per hundred thousand men in 2024 to 49.7 by 2028. Compared to 2023, there is a consistent yearly increase observed in this forecasted period, indicating a steady rise in mortality rates with a year-on-year growth of approximately 1.05%. The compound annual growth rate (CAGR) over these five years is approximately 1.04%, reflecting a modest upward trend.
Future trends to watch for include advancements in early detection and treatments, changes in lifestyle factors, and demographic shifts affecting older populations. Monitoring healthcare policy changes and technological developments in cancer treatment could alter these projections significantly.
